skip to main content
Show Results with:

9 results  for Everything in this catalogue

Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

A fully human IgG1 anti‐PD‐L1 MAb in an in vitro assay enhances antigen‐specific T‐cell responses

Grenga, Italia et al.

Clinical & translational immunology. Volume 5:Issue 5 (2016); pp n/a-n/a -- John Wiley & Sons Australia, Ltd. on behalf of Australasian Society for Immunology Inc

Online access

2
Material Type:
Article
Add to My workspace

Anti-PD-L1/TGFβR2 (M7824) fusion protein induces immunogenic modulation of human urothelial carcinoma cell lines, rendering them more susceptible to immune-mediated recognition and lysis

Grenga, Italia et al.

Urologic oncology. Volume 36:Number 3 (2018, March); pp 93.e1-93.e11 -- Elsevier Science Pub. Co

Online access

3
Material Type:
Article
Add to My workspace

Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression

Grenga, Italia et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-1 -- BioMed Central

Online access

4
Material Type:
Article
Add to My workspace

Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses

Heery, Christopher et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-2 -- BioMed Central

Online access

5
Material Type:
Article
Add to My workspace

Evaluation of immune cell subsets of cancer patients treated with Avelumab, a fully human IgG1 anti-PD-L1 MAb capable of mediating ADCC of human tumor cells

Lepone, Lauren et al.

Journal for immunotherapy of cancer. Volume 3:Issue 2 (2015); pp 1-2 -- BioMed Central

Online access

6
Material Type:
Article
Add to My workspace

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Heery, Christopher R et al.

The Lancet oncology. Volume 18:Issue 5 (2017); pp 587-598 -- Elsevier Science

Online access

7
Material Type:
Article
Add to My workspace

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

Heery, Christopher R et al.

The Lancet oncology. Volume 18:Issue 5 (2017); pp 587-598 -- Elsevier Science

Online access

8
Material Type:
Article
Add to My workspace

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Ager, Casey et al.

Journal for immunotherapy of cancer. Volume 4:Issue 1 (2016); pp 107-221 -- BioMed Central

Online access

9
Material Type:
Article
Add to My workspace

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

Ager, Casey et al.

Journal for immunotherapy of cancer. Volume 4:Issue 1 (2016); pp 107-221 -- BioMed Central

Online access

9 results  for Everything in this catalogue

Refine Search Results

Creation date 

From To

Additional Features 

  1. Abstract  (4)
  2. No Abstract  (5)
  3. Refine further open sub menu

Searching Remote Databases, Please Wait